About Us
Aplexis is a start-up biopharmaceutical company focusing on the development of small molecule inhibitors to treat myeloproliferative neoplasms.
Technology
Our Team
Jing Yang
MD, MS, Co-Founder, Chief Scientific Officer
Peng Ji
MD, PhD, Co-Founder
Gary Schiltz
PhD, Medicinal Chemist
News
Lorem ipsum dolor sit amet
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore...
Read More
Sed ut perspiciatis unde omnis
iste natus error sit voluptatem accusantium doloremque laudantium, totam rem...
Read More
Lorem ipsum dolor
sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt...
Read More